Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | — | 3.6T | 3.7T | 3.4T |
Cost of revenue | — | 3.0T | 3.1T | 2.9T |
Gross profit | — | 584.0B | 580.7B | 549.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | 418.0B | 388.8B | 363.9B |
Other operating expenses | — | — | — | — |
Operating income | — | 166.0B | 192.0B | 185.9B |
Non operating interest income | ||||
Income | — | 13.7B | 14.9B | 12.7B |
Expense | — | 25.6B | 26.3B | 25.4B |
Other income expense | — | — | — | — |
Pretax income | — | 245.9B | 278.0B | 271.6B |
Tax provision | — | 48.0B | 66.6B | 58.7B |
Net income | — | 197.9B | 211.4B | 212.9B |
Basic EPS | 143.6 | — | 137.2 | 137.3 |
Diluted EPS | 143.6 | — | 137.2 | 137.3 |
Basic average shares | 1.4B | — | 1.4B | 1.5B |
Diluted average shares | 1.4B | — | 1.4B | 1.5B |
EBITDA | — | 399.2B | 410.0B | 396.3B |
Net income from continuing op. | — | 197.9B | 211.4B | 212.9B |
Minority interests | — | -7.8B | -12.6B | -13.2B |
Preferred stock dividends | — | 0 | 0 | 0 |